X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercepharma.com/pharma/sumitomo-pharma-lays-another-400-us-staffers-face-sliding-revenues
https://bora-corp.com/bora-pharmaceuticals-to-acquire-us-pharma-manufacturer-upsher-smith-for-210-million-in-transaction-to-fuel-global-expansion/
https://www.indianpharmapost.com/news/sumitomo-pharma-announces-authorization-in-canada-of-orgovyx-for-treatment-prostate-cancer-14828
https://www.prnewswire.com/news-releases/sumitomo-pharma-announces-authorization-in-canada-of-orgovyx-relugolix-for-the-treatment-of-men-with-advanced-prostate-cancer-301963903.html
https://www.prnewswire.com/news-releases/sumitomo-pharma-and-pfizer-in-canada-receive-health-canada-approval-for-myfembree-301961837.html
https://www.prnewswire.com/news-releases/gedeon-richter-and-sumitomo-pharma-receive-positive-chmp-opinion-for-ryeqo-for-treatment-of-endometriosis-301929253.html
https://www.globenewswire.com/news-release/2023/09/12/2741272/0/en/Salipro-Biotech-enters-into-research-collaboration-with-Sumitomo-Pharma-to-advance-a-drug-discovery-program.html
https://www.prnewswire.com/news-releases/sumitomo-pharma-announces-positive-topline-results-from-phase-3-clinical-studies-evaluating-vibegron-in-men-with-overactive-bladder-symptoms-receiving-pharmacological-therapy-for-benign-prostatic-hyperplasia-301923356.html
Market Place
Share 
